Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Gene-corrected human Munc13-4–deficient CD8 + T cells can efficiently restrict EBV-driven lymphoproliferation in immunodeficient mice

Tayebeh Soheili, Julie Rivière, Ida Ricciardelli, Amandine Durand, Els Verhoeyen, Anne-Céline Derrien, Chantal Lagresle-Peyrou, Geneviève de Saint Basile, François-Loïc Cosset, Persis Amrolia, Isabelle André-Schmutz, Marina Cavazzana

Blood (2016) 128 (24): 2859–2862.

https://doi.org/10.1182/blood-2016-07-729871

Published: 2016

Includes: Supplemental data

Journal Articles

Targeting T-Cell Receptor β-Constant Domain for Immunotherapy of T-Cell Malignancies

Paul Michael Maciocia, BSc,MBBS,MRCP, Patrycja Wawrzyniecka, MSc, Brian Philip, PhD, Ida Ricciardelli, PhD, Ayse U. Akarca, BSc, Shimobi Onuoha, PhD, David Cole, PhD, Andrew Sewell, PhD, Karl S Peggs, MD, David C. Linch, MD MRCP, MB BCh, BA, Teresa Marafioti, MD, Martin A Pule, MD PhD

Blood (2016) 128 (22): 811.

https://doi.org/10.1182/blood.V128.22.811.811

Published: 2016

Journal Articles

Cord blood T cells mediate enhanced antitumor effects compared with adult peripheral blood T cells

Prashant Hiwarkar, Waseem Qasim, Ida Ricciardelli, Kimberly Gilmour, Sergio Quezada, Aurore Saudemont, Persis Amrolia, Paul Veys

Blood (2015) 126 (26): 2882–2891.

https://doi.org/10.1182/blood-2015-06-654780

Published: 2015

Includes: Supplemental data

Journal Articles

Towards gene therapy for EBV-associated posttransplant lymphoma with genetically modified EBV-specific cytotoxic T cells

Ida Ricciardelli, Michael Patrick Blundell, Jennifer Brewin, Adrian Thrasher, Martin Pule, Persis J. Amrolia

Blood (2014) 124 (16): 2514–2522.

https://doi.org/10.1182/blood-2014-01-553362

Published: 2014

Includes: Supplemental data

Journal Articles

Genetically Modified EBV-Specific Cytotoxic T Lymphocytes Induce Regression Of EBV Lymphoproliferation Despite Immunosuppression In Xenografted Mice: A Novel Strategy For EBV-Associated Post-Transplant Lymphoproliferative Disease

Ida Ricciardelli, Jenny Brewin, Mike Blundell, Martin Pule, Persis Amrolia

Blood (2013) 122 (21): 3264.

https://doi.org/10.1182/blood.V122.21.3264.3264

Published: 2013

NARROW

Gene-corrected human Munc13-4–deficient CD8 + T cells can efficiently restrict EBV-driven lymphoproliferation in immunodeficient mice

Targeting T-Cell Receptor β-Constant Domain for Immunotherapy of T-Cell Malignancies

Cord blood T cells mediate enhanced antitumor effects compared with adult peripheral blood T cells

Towards gene therapy for EBV-associated posttransplant lymphoma with genetically modified EBV-specific cytotoxic T cells

Genetically Modified EBV-Specific Cytotoxic T Lymphocytes Induce Regression Of EBV Lymphoproliferation Despite Immunosuppression In Xenografted Mice: A Novel Strategy For EBV-Associated Post-Transplant Lymphoproliferative Disease

Email alerts

ASH Publications

American Society of Hematology

Gene-corrected human Munc13-4–deficient CD8 + T cells can efficiently restrict EBV-driven lymphoproliferation in immunodeficient mice

Targeting T-Cell Receptor β-Constant Domain for Immunotherapy of T-Cell Malignancies

Cord blood T cells mediate enhanced antitumor effects compared with adult peripheral blood T cells

Towards gene therapy for EBV-associated posttransplant lymphoma with genetically modified EBV-specific cytotoxic T cells

Genetically Modified EBV-Specific Cytotoxic T Lymphocytes Induce Regression Of EBV Lymphoproliferation Despite Immunosuppression In Xenografted Mice: A Novel Strategy For EBV-Associated Post-Transplant Lymphoproliferative Disease

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only